Deepak Nitrite Subsidiary Receives ₹100 Cr Capital Infusion

Key Details • DCTL (wholly owned subsidiary) received ₹100 Cr investment • Investment routed via DPL through 1 crore preference shares • Purpose: Strengthen capital base and fund project & corporate expenses • DCTL FY25 turnover: ₹9.43 Cr • Operates fluorination plant and related projects in Gujarat • Post-investment, Deepak Nitrite & DPL hold 100% of equity and preference capital Why It Matters Capital infusion improves subsidiary balance sheet strength and supports project execution. Preference shares help raise funds without immediate equity dilution at the parent level. Learning Outcome In capital allocation announcements, investors should assess funding structure (equity vs preference), purpose of funds, and subsidiary scale to understand long-term return potential.